THE EDITORIAL NEWS

ZAMBIA COMMISSIONS US$340 MLN ANTI-CLIMATE CHANGE PHOSPHATE PLANT By Jeff Kapembwa China-owned Sino Great Group, through its subsidiary Sino Great Chemical Company Limited, and Zambia’s Wonderful Group of Companies Limited have commissioned a US$340 million environmental friendly phosphate producing plant in Zambia,  authenticating United Nations’ call for reduced gas emissions by 2035 to save the environment. Under the United Nations’ global resolve, all member countries should endeavour to collectively and without delay commit to cutting 42 per cent of annual greenhouse gas emissions by 2030 and 57 per cent by 2035 in the next decade and save the environment and human life. The UN Secretary General in his warning to polluters categorically called for concerted action by all to save the planet. He urges all players, individual and industry alike, to demonstrate increased ambition and commitment.for reduced emissions to reduce temperature to less than 1.5 d...

 ZAMBIA  APPROVES HIV VACCINE TRIALS .... As the Authority issues 39 GMO Permits Lackson Tonga -NBA CEO By Alfonso Kasongo Zambia has approved a clinical trial of an HIV vaccine to be undertaken by the Centre for  Family Health Research in Zambia (CFHRZ) ,country's biosafety regulator has  announced. The National Biosafety Authority (NBA) Board ,during its extra ordinary meeting held last week, approved the vaccine trial permit application for CFHRZ. The experimental medicine vaccine trial will be administered to People Living with HIV (PLWH). With over 1.3 million people living with HIV (PLHIV), Zambia, t he  southern African  nation   is one of the countries most affected by HIV globally and the pandemic is the leading cause of death in country. The country has an estimate HIV prevalence of  about 11 % between the ages of 15-49,this is according to CDC 2022 report . According to  the press statement released by the Authority communicat...

  KENYAN  FARMERS  MISSED OUT  OVER USD 150 MILLION REVENUE DUE TO DELAYS IN APPROVING GMO CROPS   By Alfonso Kasongo A study has revealed that Kenyan  farmers incurred a fiscal loss amounting to estimated USD 157 million in 5  years as a result of the delays in the approval of genetically modified cotton, maize, and late blight disease- resistant potato,when the crops have the potential to generate USD 467 million in benefits over 30 years for the country . ' The  Alliance for Science launched a groundbreaking report  ,dubbed  Genetically Modified Crops in Kenya: The Cost of Regulatory Delay, offers a critical analysis of the economic opportunities lost due to delayed adoption of GM technology in the Eastern African Nation. The study quantifies the economic damage triggered by the anti-GMO movement as well as delays in the approval and commercialization of genetically modified crops in the Eastern African nation. Fur...